Abulsalam Abdullah Al, Kindi Khawla Al, Ghailani Abdullah Al, Sinawi Hamed Al, Balushi Naser Al, Kindi Salam Al, Murthi Sathiya P, Fahdi Amal Al, Al Alawi Mohammed
Department of Behavioural Medicine, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman.
Psychiatry Residency Programme, Oman Medical Specialty Board, Muscat, Oman.
Sultan Qaboos Univ Med J. 2025 May 2;25(1):674-680. doi: 10.18295/2075-0528.2888. eCollection 2025.
This study aimed to assess the prevalence of aberrant opioid-related behaviours (AORB) among patients with sickle cell disease (SCD) in Oman and identify associated risk factors.
This cross-sectional analytical study was conducted at Sultan Qaboos University Hospital, Muscat, Oman from June to December 2022. Patients with SCD aging 18-65 years old were included and clinically observed for more than 3 months. The Current Opioid Misuse Measure (COMM) was used to evaluate AORB with scores of ≥9 indicating high risk. Demographic and clinical data were collected. The association between AORB and clinical-demographic variables was examined using the Chi-square test.
A total of 144 SCD patients were included in this study; 58.3% of the participants were at high risk of AORB with a mean COMM score of 12.08. A significant relationship was found between perceived lack of family social support and AORB ( <0.001). No significant associations were observed between AORB risk and other studied factors.
This study was the first to document a high prevalence of AORB among SCD patients in Oman. The findings underscore the critical role of family support in mitigating this risk of opioid misuse among this vulnerable population.
本研究旨在评估阿曼镰状细胞病(SCD)患者中异常阿片类药物相关行为(AORB)的患病率,并确定相关风险因素。
本横断面分析研究于2022年6月至12月在阿曼马斯喀特的苏丹·卡布斯大学医院进行。纳入年龄在18 - 65岁的SCD患者,并进行超过3个月的临床观察。使用当前阿片类药物滥用测量量表(COMM)评估AORB,得分≥9表明高风险。收集人口统计学和临床数据。使用卡方检验检查AORB与临床人口统计学变量之间的关联。
本研究共纳入144例SCD患者;58.3%的参与者存在AORB高风险,平均COMM得分为12.08。发现感知到的家庭社会支持不足与AORB之间存在显著关系(<0.001)。未观察到AORB风险与其他研究因素之间存在显著关联。
本研究首次记录了阿曼SCD患者中AORB的高患病率。研究结果强调了家庭支持在减轻这一弱势群体中阿片类药物滥用风险方面的关键作用。